Shopping Cart
- Remove All
- Your shopping cart is currently empty
Rilzabrutinib (PRN1008) is a reversible covalent, selective, and orally active inhibitor of Bruton’s Tyrosine Kinase (BTK) with an IC50 of 1.3 nM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $100 | In Stock | |
5 mg | $247 | In Stock | |
10 mg | $396 | In Stock | |
25 mg | $689 | In Stock | |
50 mg | $993 | In Stock | |
100 mg | $1,390 | In Stock | |
500 mg | $2,780 | In Stock | |
1 mL x 10 mM (in DMSO) | $362 | In Stock |
Description | Rilzabrutinib (PRN1008) is a reversible covalent, selective, and orally active inhibitor of Bruton’s Tyrosine Kinase (BTK) with an IC50 of 1.3 nM. |
Targets&IC50 | RLK:1.2 nM, EGFR:520 nM, BLK:6.3 nM, BTK:1.3 nM, ERB4:11.3 nM, BMX:1.0 nM, ITK:440 nM, TEC:0.8 nM, ErbB2:3900 nM |
Alias | PRN1008 |
Molecular Weight | 665.76 |
Formula | C36H40FN9O3 |
Cas No. | 1575596-29-0 |
Smiles | CC(C)(\C=C(/C#N)C(=O)N1CCC[C@H](C1)n1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc12)N1CCN(CC1)C1COC1 |
Relative Density. | 1.39 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 130 mg/mL (195.27 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.